Fundraising Fox
Prellis
Hayward, US · Founded 2017 · Delaware corporation · 64 employees on LinkedIn · 11 known investors
Find your way into Prellis
Sign up to see every warm intro you have to Prellis
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Prellis team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Prellis Biologics runs an antibody discovery platform that uses two-photon laser-bioprinted human immune organoids combined with machine learning to identify fully human antibody therapeutics. It develops a portfolio of antibody drug candidates across multiple disease areas and partners with biotech and pharmaceutical companies.
Founders & leadership
Prellis was founded in 2017 by Melanie Matheu and Noelle Mullin.
Board
Investors · 11
How we know: Black Diamond Ventures's portfolio page · Not right? Tell us
How we know: Celesta Capital's portfolio page · a partner's Signal profile · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Civilization Ventures Management, Llc's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: plugandplaytechcenter.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · sosv.com · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$47.3M disclosed across 5 rounds · 2017–2022
▶$17MraisedJul 2022 · 19 investors · Other TechnologyRule 506(b)
- Michael MarksDirector
- Sean O'SullivanDirector
- Melanie MatheuExecutive Officer, Director
- Alex MorganDirector
- Shaun HoltDirector
- Lei MengDirector
- Offering amount
- $35M
- Amount sold
- $17M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$19.3MraisedJul 2021 · 9 investors · Other TechnologyRule 506(b)
- Arvind GuptaDirector
- Michael MarksDirector
- Shaun HoltDirector
- Alex MorganDirector
- Melanie MatheuExecutive Officer, Director
- Offering amount
- $19.3M
- Amount sold
- $19.3M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$8.7MraisedMar 2019 · 11 investors · Other TechnologyRule 506(b)
- Melanie MatheuExecutive Officer, Director
- Rohit SharmaDirector
- Arvind GuptaDirector
- Offering amount
- $9.2M
- Amount sold
- $8.7M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$460KraisedFeb 2018 · 2 investors · BiotechnologyRule 506(b)
- Arvind GuptaDirector
- Melanie MatheuExecutive Officer, Director
- Noelle MullinExecutive Officer, Director
- Rohit SharmaDirector
- Offering amount
- $1M
- Amount sold
- $460K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.8MraisedJul 2017 · 2 investors · Other TechnologyRule 506(b)
- Noelle MullinExecutive Officer, Director
- Melanie MatheuExecutive Officer, Director
- Arvind GuptaDirector
- Rohit SharmaDirector
- Offering amount
- $2.1M
- Amount sold
- $1.8M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Prellis went on to found or lead other companies.
Related companies · 7
Companies working in the same space as Prellis.
Frequently asked questions
- What does Prellis do?
- Prellis Biologics runs an antibody discovery platform that uses two-photon laser-bioprinted human immune organoids combined with machine learning to identify fully human antibody therapeutics. It develops a portfolio of antibody drug candidates across multiple disease areas and partners with biotech and pharmaceutical companies.
- Who founded Prellis?
- Prellis was founded by Melanie Matheu, Noelle Mullin in 2017.
- Who are Prellis's investors?
- Prellis's investors include Black Diamond Ventures, Celesta Capital, Civilization Ventures Management, Llc, Open Field Capital, Plug and Play Ventures, Prefix Capital, SOSV, Cantos Ventures and 3 more.
- How much funding has Prellis raised?
- Prellis has disclosed $47.3M raised across 5 rounds.
- Where is Prellis headquartered?
- Prellis is headquartered in Hayward, US.